Medicis, Ranbaxy Forge Pact For Solodyn Generic
Medicis Pharmaceutical Corp. has reached consent and licensing agreements with Indian generics maker Ranbaxy Laboratories Inc., settling patent infringement claims against Ranbaxy over Medicis' oral acne drug Solodyn and enjoining Ranbaxy...To view the full article, register now.
Already a subscriber? Click here to view full article